Vencanna VenturesVENCF +80.00% Days Payable is 266.08 as of Jan. 2026, which is 66% above its 10-year median of 160.18. The stock has 4 warning signs investors should review. Among 923 Drug Manufacturers companies, Vencanna Ventures ranks better than 79.96% on this metric.
The historical rank and industry rank for Vencanna Ventures's Days Payable or its related term are showing as below:
VENCF'
s Days Payable Range Over the Past 10 Years
Min: 160.18 Med: 160.18 Max: 171.5
Current: 171.5
During the past 13 years, Vencanna Ventures's highest Days Payable was 171.50. The lowest was 160.18. And the median was 160.18.
VENCF's Days Payable is ranked better than 79.96% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs VENCF: 171.50
Vencanna Ventures's Days Payable
declined
from Jan. 2025 (268.77) to Jan. 2026 (266.08).
It may suggest that Vencanna Venturesaccelerated paying its suppliers.
Vencanna Ventures Days Payable Related Terms
Vencanna Ventures Days Payable Historical Data
* Premium members only.
The historical data trend for Vencanna Ventures's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vencanna Ventures's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vencanna Ventures Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vencanna Ventures's Days Payable distribution charts can be found below:
* The bar in red indicates where Vencanna Ventures's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Vencanna Ventures's Days Payable for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vencanna Ventures (VENCF) has a Days Payable of 266.08 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vencanna Ventures and its competitors. This is 66% above median its historical median of 160.18. Over the past decade, Vencanna Ventures' Days Payable has ranged from 160.18 to 171.50. According to the industry distribution chart, Vencanna Ventures ranks #185 out of 923 companies in the Drug Manufacturers industry, placing it in the top 20%.
Is Vencanna Ventures' Days Payable too high?
Vencanna Ventures' current Days Payable of 266.08 is 66% above median its 10-year median of 160.18. Over the past 10 years, this metric has ranged from a low of 160.18 to a high of 171.50. The Drug Manufacturers industry median Days Payable is 90.98. Vencanna Ventures' value of 266.08 is 192.5% above this industry median. Based on the distribution chart, Vencanna Ventures ranks #185 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Vencanna Ventures' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #185 out of 923 companies for Days Payable. This places Vencanna Ventures in the top 20% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.98. Vencanna Ventures' value of 266.08 is 192.5% above this benchmark. Historically, Vencanna Ventures' own Days Payable has ranged from 160.18 to 171.50 over the past decade. While the company's 10-year median is 160.18 vs. the industry median of 90.98, Vencanna Ventures has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vencanna Ventures's current Days Payable of 266.08 is 192.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current Days Payable is 266.08, which is 66% above median its own 10-year median of 160.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current Days Payable of 266.08. The current Days Payable is 266.08, which is 66% above median its 10-year median of 160.18 and 192.5% above the Drug Manufacturers industry median of 90.98. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current Days Payable is 266.08 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VENCF has been successfully added to your 